US6262096B1
(en)
|
1997-11-12 |
2001-07-17 |
Bristol-Myers Squibb Company |
Aminothiazole inhibitors of cyclin dependent kinases
|
DE69923681T2
(de)
*
|
1998-06-18 |
2006-01-12 |
Bristol-Myers Squibb Co. |
Kohlenstoff substituierte aminothiazole als inhibitoren von cyclin-abhängigen kinasen
|
US6407124B1
(en)
|
1998-06-18 |
2002-06-18 |
Bristol-Myers Squibb Company |
Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
|
US6214852B1
(en)
|
1998-10-21 |
2001-04-10 |
Bristol-Myers Squibb Company |
N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases
|
US6414156B2
(en)
|
1998-10-21 |
2002-07-02 |
Bristol-Myers Squibb Company |
Process for preparing azacycloalkanoylaminothiazoles
|
US6320050B1
(en)
|
1999-03-29 |
2001-11-20 |
Hoffmann-La Roche Inc. |
Heteroaromatic glucokinase activators
|
US6610846B1
(en)
|
1999-03-29 |
2003-08-26 |
Hoffman-La Roche Inc. |
Heteroaromatic glucokinase activators
|
US7125875B2
(en)
|
1999-04-15 |
2006-10-24 |
Bristol-Myers Squibb Company |
Cyclic protein tyrosine kinase inhibitors
|
RU2312860C2
(ru)
|
1999-04-15 |
2007-12-20 |
Бристол-Маерс Сквибб Компани |
Циклические ингибиторы протеинтирозинкиназ
|
AR030154A1
(es)
|
1999-07-05 |
2003-08-13 |
Nihon Nohyaku Co Ltd |
Derivado de ftalamida, derivado de amina heterociclico util como intermediario para la produccion del mismo, insecticida agrohorticola y metodo para utilizar dicho insecticida
|
US6114365A
(en)
*
|
1999-08-12 |
2000-09-05 |
Pharmacia & Upjohn S.P.A. |
Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents
|
US6515004B1
(en)
|
1999-12-15 |
2003-02-04 |
Bristol-Myers Squibb Company |
N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases
|
US6392053B2
(en)
|
1999-12-15 |
2002-05-21 |
Bristol-Myers Squibb Company |
Process for preparing arylacetylaminothiazoles
|
IT1317826B1
(it)
*
|
2000-02-11 |
2003-07-15 |
Dompe Spa |
Ammidi, utili nell'inibizione della chemiotassi dei neutrofiliindotta da il-8.
|
DE10037310A1
(de)
*
|
2000-07-28 |
2002-02-07 |
Asta Medica Ag |
Neue Indolderivate und deren Verwendung als Arzneimittel
|
US6716995B2
(en)
|
2000-08-17 |
2004-04-06 |
Lumera Corporation |
Design and synthesis of advanced NLO materials for electro-optic applications
|
CA2430151A1
(en)
*
|
2000-11-27 |
2002-06-20 |
Pharmacia Italia S.P.A. |
Phenylacetamido- pyrazole derivatives and their use as antitumor agents
|
ATE318812T1
(de)
|
2000-12-21 |
2006-03-15 |
Bristol Myers Squibb Co |
Thiazolyl-inhibitoren von tyrosinkinasen der tec- familie
|
US6756374B2
(en)
|
2001-01-22 |
2004-06-29 |
Hoffmann-La Roche Inc. |
Diaminothiazoles having antiproliferative activity
|
EP1256578B1
(en)
*
|
2001-05-11 |
2006-01-11 |
Pfizer Products Inc. |
Thiazole derivatives and their use as cdk inhibitors
|
SE0102299D0
(sv)
|
2001-06-26 |
2001-06-26 |
Astrazeneca Ab |
Compounds
|
HN2002000156A
(es)
|
2001-07-06 |
2003-11-27 |
Inc Agouron Pharmaceuticals |
Derivados de benzamida tiazol y composiciones farmaceuticas para inhibir la proliferacion de celulas y metodos para su utilización.
|
IL159570A0
(en)
*
|
2001-07-19 |
2004-06-01 |
Pharmacia Italia Spa |
Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
|
EP1724270A3
(en)
|
2001-07-19 |
2007-01-03 |
Pfizer Italia S.r.l. |
Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
|
EP2335700A1
(en)
|
2001-07-25 |
2011-06-22 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis C virus polymerase inhibitors with a heterobicylic structure
|
SE0102764D0
(sv)
|
2001-08-17 |
2001-08-17 |
Astrazeneca Ab |
Compounds
|
JP2005504790A
(ja)
*
|
2001-09-13 |
2005-02-17 |
シンタ ファーマスーティカルズ コーポレイション |
癌を治療するための3−グリオキシリルアミドインドール
|
CA2469228A1
(en)
*
|
2001-12-03 |
2003-06-12 |
Japan Tobacco Inc. |
Azole compound and medicinal use thereof
|
EP1496052B1
(en)
|
2002-03-26 |
2009-08-05 |
Banyu Pharmaceutical Co., Ltd. |
Novel aminobenzamide derivative
|
CN100357283C
(zh)
*
|
2002-04-02 |
2007-12-26 |
中国科学院上海药物研究所 |
一类甲硫氨酰氨肽酶抑制剂
|
SE0201194D0
(sv)
*
|
2002-04-19 |
2002-04-19 |
Astrazeneca Ab |
New compounds
|
CA2482346C
(en)
|
2002-04-26 |
2010-03-09 |
F. Hoffmann-La Roche Ag |
Substituted phenylacetamides and their use as glucokinase activators
|
WO2004014388A1
(en)
*
|
2002-08-13 |
2004-02-19 |
Warner-Lambert Company Llc |
6,6-fused heteroaryl derivatives as matrix metalloproteinase inhibitors
|
CA2498089A1
(en)
*
|
2002-10-03 |
2004-06-17 |
Novartis Ag |
Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes
|
EP1558607B1
(en)
*
|
2002-10-30 |
2010-05-05 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of rock and other protein kinases
|
GB0226931D0
(en)
*
|
2002-11-19 |
2002-12-24 |
Astrazeneca Ab |
Chemical compounds
|
MY141521A
(en)
|
2002-12-12 |
2010-05-14 |
Hoffmann La Roche |
5-substituted-six-membered heteroaromatic glucokinase activators
|
FR2850380B1
(fr)
*
|
2003-01-23 |
2006-07-07 |
Sanofi Synthelabo |
Derives d'acylaminothiazole, leur preparation et leur utilisation en therapeutique
|
ATE524452T1
(de)
*
|
2003-03-27 |
2011-09-15 |
Cytokinetics Inc |
Sulfonamide zur behandlung von kongestivem herzversagen, deren zusammensetzungen und verwendungen.
|
EP1610776A4
(en)
*
|
2003-03-27 |
2007-03-28 |
Merck & Co Inc |
OPHTHALMIC COMPOSITIONS FOR THE TREATMENT OF OCCULAR HYPERTONIA
|
EP1664006A2
(en)
*
|
2003-09-06 |
2006-06-07 |
Vertex Pharmaceuticals Incorporated |
Modulators of atp-binding cassette transporters
|
BRPI0415179A
(pt)
*
|
2003-10-07 |
2006-11-28 |
Renovis Inc |
derivados de amida como ligandos de canal de ìon e composições farmacêuticas e métodos de empregar as mesmas
|
TW200524887A
(en)
*
|
2003-10-27 |
2005-08-01 |
Lundbeck & Co As H |
N-thiazol-2-yl-benzamide derivatives
|
ZA200605624B
(en)
|
2004-01-12 |
2007-11-28 |
Applied Research Systems |
Thiazole derivatives and use thereof
|
EP1555264A1
(en)
*
|
2004-01-15 |
2005-07-20 |
Sireen AG |
Five-membered heterocyclic compounds as inhibitors of SRC family protein kinase.
|
AU2005210474B2
(en)
*
|
2004-01-30 |
2011-07-07 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-Binding cassette transporters
|
US7977322B2
(en)
|
2004-08-20 |
2011-07-12 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-binding cassette transporters
|
EP1718608B1
(en)
|
2004-02-20 |
2013-07-17 |
Boehringer Ingelheim International GmbH |
Viral polymerase inhibitors
|
US7384968B2
(en)
*
|
2004-04-01 |
2008-06-10 |
Pfizer Inc. |
Thiazole-amine compounds for the treatment of neurodegenerative disorders
|
FR2868421B1
(fr)
|
2004-04-01 |
2008-08-01 |
Aventis Pharma Sa |
Nouveaux benzothiazoles et leur utilisation comme medicaments
|
US7211576B2
(en)
|
2004-04-20 |
2007-05-01 |
Hoffmann-La Roche Inc. |
Diaminothiazoles
|
UA90864C2
(en)
*
|
2004-09-09 |
2010-06-10 |
Ромарк Лебораториз, Л.К. |
Halogenated benzamide derivatives
|
EP1794157B1
(en)
|
2004-09-22 |
2014-02-26 |
H. Lundbeck A/S |
2-acylaminothiazole derivatives
|
US20080096848A1
(en)
*
|
2004-09-29 |
2008-04-24 |
Cytovia Inc. |
Substituted N-Aryl-9-Oxo-9H-Fluorene-1-Carboxamides and Analogs as Activators of Caspases and Inducers of Apoptosis
|
US20080171788A1
(en)
*
|
2005-02-08 |
2008-07-17 |
Shinobu Akuzawa |
Medicament For Irritable Bowel Syndrome
|
MX2007010414A
(es)
*
|
2005-03-04 |
2007-09-25 |
Hoffmann La Roche |
Derivados de piridin-2-carboxamida como antagonistas de mglur5.
|
TW200720264A
(en)
*
|
2005-04-25 |
2007-06-01 |
Lundbeck & Co As H |
Pro-drugs of n-thiazol-2-yl-benzamide derivatives
|
US7674912B2
(en)
|
2005-04-25 |
2010-03-09 |
H. Lundbeck A/S |
Pro-drugs of N-thiazol-2-yl-benzamide derivatives
|
WO2006125324A1
(en)
*
|
2005-05-27 |
2006-11-30 |
Queen's University At Kingston |
Treatment of protein folding disorders
|
KR100965040B1
(ko)
|
2005-07-11 |
2010-06-21 |
미쓰비시 타나베 파마 코퍼레이션 |
옥심 유도체 및 그의 제조 방법
|
KR20080080170A
(ko)
*
|
2005-12-12 |
2008-09-02 |
제네랩스 테크놀로지스, 인코포레이티드 |
N-(5원 헤테로방향족 고리)-아미도 항바이러스 화합물
|
ES2761180T3
(es)
*
|
2005-12-23 |
2020-05-19 |
Ariad Pharma Inc |
Compuestos bicíclicos de heteroarilo
|
EP1849785A1
(en)
*
|
2006-04-28 |
2007-10-31 |
Neuropharma, S.A. |
N-(2-Thiazolyl)-amide derivatives as GSK-3 inhibitors
|
BRPI0710331A2
(pt)
|
2006-05-08 |
2012-03-20 |
Ariad Pharmaceuticals, Inc |
Compostos heteroarila monocíclicos para tratamento de câncer e composição
|
KR20090018104A
(ko)
|
2006-05-08 |
2009-02-19 |
어리어드 파마슈티칼스, 인코포레이티드 |
아세틸렌계 헤테로아릴 화합물
|
US20090291976A1
(en)
*
|
2006-06-27 |
2009-11-26 |
Peter Andrew Ferchmin |
Neuronal circuit-dependent neuroprotection by interaction between nicotinic receptors
|
EP2105435A4
(en)
|
2007-01-10 |
2011-06-15 |
Mitsubishi Tanabe Pharma Corp |
Hydrazone derivatives
|
WO2008084873A1
(ja)
*
|
2007-01-10 |
2008-07-17 |
Mitsubishi Tanabe Pharma Corporation |
オキシム誘導体
|
MX2009013169A
(es)
*
|
2007-06-03 |
2010-04-30 |
Univ Vanderbilt |
Moduladores alostericos positivos del mglur5 benzamida y metodos de elaboracion y uso de los mismos.
|
US8853392B2
(en)
|
2007-06-03 |
2014-10-07 |
Vanderbilt University |
Benzamide mGluR5 positive allosteric modulators and methods of making and using same
|
AU2008283357B2
(en)
*
|
2007-07-31 |
2011-08-11 |
Shionogi & Co., Ltd. |
Pharmaceutical composition containing optically active compound having thrombopoietin receptor agonist activity and intermediate thereof
|
EP2020232A1
(en)
*
|
2007-08-03 |
2009-02-04 |
Zeltia, S.A. |
N-(1-thiazolyl)-amide derivatives for the treatment of obesity, diabetes and cardiovascular diseases
|
AU2008299781B2
(en)
*
|
2007-08-03 |
2013-11-14 |
Romark Laboratories L.C. |
Alkylsulfonyl-substituted thiazolide compounds
|
ES2322121B1
(es)
*
|
2007-12-10 |
2010-04-19 |
Consejo Superior De Investigaciones Cientificas |
Nuevos derivados de aminoacidos dicarboxilicos y su aplicacion en el tratamiento de enfermedades neurodegenerativas.
|
JP5559702B2
(ja)
*
|
2008-02-25 |
2014-07-23 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
グルコキナーゼ活性化剤
|
US10793515B2
(en)
|
2008-03-19 |
2020-10-06 |
Aurimmed Pharma, Inc. |
Compounds advantageous in the treatment of central nervous system diseases and disorders
|
WO2009117515A2
(en)
*
|
2008-03-19 |
2009-09-24 |
Aurimmed Pharma, Inc. |
Novel compounds advantageous in the treatment of central nervous system diseases and disorders
|
CN102036963B
(zh)
|
2008-05-23 |
2013-08-21 |
诺瓦提斯公司 |
作为蛋白酪氨酸激酶抑制剂的喹啉类和喹喔啉类衍生物
|
NZ590355A
(en)
*
|
2008-07-10 |
2013-01-25 |
Yakult Honsha Kk |
Stat3 inhibitor containing quinolinecarboxamide derivative as active ingredient
|
US8846664B2
(en)
|
2008-11-12 |
2014-09-30 |
Ariad Pharmaceuticals, Inc. |
Pyrazinopyrazines and derivatives as kinase inhibitors
|
US8835644B2
(en)
|
2009-03-20 |
2014-09-16 |
University Of Virginia Patent Foundation |
Broad spectrum benzothiophene-nitrothiazolide and other antimicrobials
|
CN102803203B
(zh)
|
2009-05-12 |
2016-05-11 |
罗马克实验室有限公司 |
卤代烷基杂芳基苯甲酰胺化合物
|
EP2440556A1
(en)
*
|
2009-06-10 |
2012-04-18 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of phosphatidylinositol 3-kinase
|
CN108042535A
(zh)
|
2009-06-26 |
2018-05-18 |
罗马克实验室有限公司 |
用于治疗流感的化合物和方法
|
WO2011076732A1
(en)
*
|
2009-12-21 |
2011-06-30 |
Euroscreen S.A. |
Compounds, pharmaceutical composition and methods for use in treating gastrointestinal disorders
|
WO2011076734A1
(en)
*
|
2009-12-21 |
2011-06-30 |
Euroscreen S.A. |
Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
|
AU2011265047B2
(en)
|
2010-06-07 |
2014-10-23 |
Novomedix, Llc |
Furanyl compounds and the use thereof
|
EP2594555B1
(en)
*
|
2010-07-02 |
2018-03-07 |
ASKA Pharmaceutical Co., Ltd. |
HETEROCYCLIC COMPOUND, AND p27 KIP1 DEGRADATION INHIBITOR
|
KR101688978B1
(ko)
*
|
2010-08-18 |
2016-12-26 |
중앙대학교 산학협력단 |
신규한 2-아미노 티아졸 유도체 및 이를 포함하는 항암용 조성물
|
US9333193B2
(en)
|
2010-09-20 |
2016-05-10 |
University Of Virginia Patent Foundation |
Compositions and methods for treating tuberculosis
|
CN103269593A
(zh)
*
|
2010-11-01 |
2013-08-28 |
罗马克实验室有限公司 |
烷基亚磺酰基取代的噻唑化物化合物
|
EP2651930B1
(en)
*
|
2010-12-16 |
2015-10-28 |
Boehringer Ingelheim International GmbH |
Biarylamide inhibitors of leukotriene production
|
US20120225846A1
(en)
*
|
2011-03-02 |
2012-09-06 |
Bioenergenix |
Heterocyclic compounds for the inhibition of pask
|
PT3738434T
(pt)
*
|
2011-12-28 |
2023-11-13 |
Global Blood Therapeutics Inc |
Intermediários para obter compostos de benzaldeído substituído e métodos para a sua utilização no aumento da oxigenação de tecidos
|
ES2790358T3
(es)
|
2011-12-28 |
2020-10-27 |
Global Blood Therapeutics Inc |
Compuestos de heteroaril aldehído sustituido y métodos para su uso en el aumento de la oxigenación tisular
|
TWI628170B
(zh)
*
|
2013-02-05 |
2018-07-01 |
先正達合夥公司 |
植物生長調節化合物
|
DE102013204097A1
(de)
*
|
2013-03-11 |
2014-10-30 |
Beiersdorf Ag |
Wirkstoffkombinationen aus Alkylamidothiazolen und einer oder mehreren kosmetisch oder dermatologisch unbedenklichen UV-Filtersubstanzen
|
DE102013204088A1
(de)
*
|
2013-03-11 |
2014-09-11 |
Beiersdorf Ag |
Wirkstoffkombinationen aus Alkylamidothiazolen und einen oder mehreren kosmetisch oder dermatologisch relevanten Duftstoffen
|
DE102013204081A1
(de)
*
|
2013-03-11 |
2014-09-11 |
Beiersdorf Ag |
Wirkstoffkombinationen aus Alkylamidothiazolen und einen oder mehreren kosmetisch oder dermatologisch unbedenklichen Konservierungsmitteln
|
US10100043B2
(en)
|
2013-03-15 |
2018-10-16 |
Global Blood Therapeutics, Inc. |
Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
|
AU2014254392B2
(en)
*
|
2013-03-15 |
2018-05-24 |
Epizyme, Inc. |
Substituted benzene compounds
|
PE20160078A1
(es)
|
2013-03-15 |
2016-03-02 |
Global Blood Therapeutics Inc |
Compuestos y sus usos para modular la hemoglobina
|
US9243001B2
(en)
|
2013-03-15 |
2016-01-26 |
Epizyme, Inc. |
Substituted benzene compounds
|
US9458139B2
(en)
|
2013-03-15 |
2016-10-04 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
US9422279B2
(en)
|
2013-03-15 |
2016-08-23 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
CN105073728A
(zh)
|
2013-03-15 |
2015-11-18 |
全球血液疗法股份有限公司 |
化合物及其用于调节血红蛋白的用途
|
US8952171B2
(en)
|
2013-03-15 |
2015-02-10 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
EA033555B1
(ru)
|
2013-03-15 |
2019-10-31 |
Global Blood Therapeutics Inc |
Фармацевтические композиции для лечения серповидно-клеточного нарушения
|
US10266551B2
(en)
|
2013-03-15 |
2019-04-23 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
EA201992707A1
(ru)
|
2013-11-18 |
2020-06-30 |
Глобал Блад Терапьютикс, Инк. |
Соединения и их применения для модуляции гемоглобина
|
EP2878339A1
(en)
|
2013-12-02 |
2015-06-03 |
Siena Biotech S.p.A. |
SIP3 antagonists
|
MY189995A
(en)
|
2014-02-07 |
2022-03-22 |
Global Blood Therapeutics Inc |
Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
|
CN105017174B
(zh)
*
|
2015-07-13 |
2017-03-15 |
南华大学 |
N‑(4‑烷基‑5‑苄基噻唑‑2‑基)烯酰胺及其制备方法与应用
|
CN106467499A
(zh)
*
|
2015-08-18 |
2017-03-01 |
湖南大学 |
N-(4-烷基-5-苄基噻唑-2-基)苯烷酰胺及其作为抗癌药的应用
|
CN105254585A
(zh)
*
|
2015-11-18 |
2016-01-20 |
泰山医学院 |
噻唑酰胺类化合物及其制备方法和应用
|
US11020382B2
(en)
|
2015-12-04 |
2021-06-01 |
Global Blood Therapeutics, Inc. |
Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
|
AR108435A1
(es)
|
2016-05-12 |
2018-08-22 |
Global Blood Therapeutics Inc |
Proceso para sintetizar 2-hidroxi-6-((2-(1-isopropil-1h-pirazol-5-il)-piridin-3-il)metoxi)benzaldehído
|
CN107365280B
(zh)
*
|
2016-05-13 |
2020-11-06 |
湖南大学 |
N-(噻唑-2-基)哌嗪基酰胺衍生物及其作为抗癌药物的应用
|
US11697851B2
(en)
|
2016-05-24 |
2023-07-11 |
The Regents Of The University Of California |
Early ovarian cancer detection diagnostic test based on mRNA isoforms
|
WO2017219083A1
(en)
*
|
2016-06-21 |
2017-12-28 |
The University Of Melbourne |
Activators of hiv latency
|
TWI778983B
(zh)
|
2016-10-12 |
2022-10-01 |
美商全球血液治療公司 |
包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
|
US20180289676A1
(en)
*
|
2017-03-30 |
2018-10-11 |
Saint Louis University |
Compounds and methods targeting gper in cancer
|
CN111032653A
(zh)
*
|
2017-06-14 |
2020-04-17 |
欧洲分子生物学实验室 |
用于疗法的双环杂芳族酰胺化合物
|
WO2019241376A1
(en)
*
|
2018-06-14 |
2019-12-19 |
The Trustees Of Columbia University In The City Of New York |
Treatment of cognitive disorders using nitazoxanide (ntz), nitazoxanide (ntz) analogs, and metabolites thereof
|
ES2966707T3
(es)
|
2018-10-01 |
2024-04-23 |
Global Blood Therapeutics Inc |
Moduladores de la hemoglobina para el tratamiento de la drepanocitosis
|
US20210380546A1
(en)
*
|
2018-10-22 |
2021-12-09 |
The Regents Of The University Of California |
Vaccine adjuvant
|
EP4039679A4
(en)
*
|
2019-10-04 |
2023-08-30 |
Parenchyma Biotech Inc. |
NEW COMPOUND AND ITS USE TO TREAT AUTOIMMUNE DISEASES
|
US20230020507A1
(en)
*
|
2019-10-04 |
2023-01-19 |
Parenchyma Biotech Inc. |
Compound and use thereof in treating autoimmune diseases
|
EP3827816A1
(en)
|
2019-11-28 |
2021-06-02 |
Universitätsmedizin der Johannes Gutenberg-Universität Mainz |
Prooxidative chain-transfer agents for use in the treatment of malignant tumour or infectious diseases
|
CN111533735A
(zh)
*
|
2020-05-08 |
2020-08-14 |
张建蒙 |
氧代二氢哒嗪噻唑类衍生物及其在抗肿瘤药物中的应用
|
AU2021359129A1
(en)
*
|
2020-10-16 |
2023-06-01 |
Proxygen Gmbh |
Heterocyclic cullin ring ubiquitin ligase compounds and uses thereof
|
WO2023275796A1
(en)
*
|
2021-07-01 |
2023-01-05 |
Novartis Ag |
Heterocyclic derivatives as sphingosine-1-phosphate 3 inhibitors
|
WO2023131690A1
(en)
*
|
2022-01-10 |
2023-07-13 |
Merck Patent Gmbh |
Substituted heterocycles as hset inhibitors
|
WO2023203172A1
(en)
*
|
2022-04-20 |
2023-10-26 |
Proxygen Gmbh |
Heterocyclic cullin ring ubiquitin ligase compounds and uses thereof
|
CN114874155B
(zh)
*
|
2022-05-10 |
2024-02-06 |
华南理工大学 |
一类苄基噻唑胺类化合物及其制备方法与抗肿瘤应用
|
CN117229275A
(zh)
*
|
2023-08-15 |
2023-12-15 |
北京中医药大学 |
一种新型2-乙酰氨基噻唑化合物及其制备方法与应用
|